Navigation Links
Hamilton Thorne announces third quarter results
Date:11/24/2009

700 Changes in operating assets and liabilities: Accounts receivable 108,158 409,521 (367,418) 193,048 Inventories 128,411 60,863 122,638 24,458 Prepaid expenses and other current assets 3,673 38,415 11,835 22,505 Other assets (402,127) (7,771) (392,725) (5,059) Accounts payable, trade 531,776 1,406 553,362 2,710 Accrued expenses and other current liabilities 35,270 (331,365) (10,677) (42,479) Deferred revenue 7,645 4,127 11,000 1,931 ------------------------------------------------------------------------- Net cash used in operating activities (458,102) (714,575) (184,063) (43,453) ------------------------------------------------------------------------- Cash flows from investing activities: Purchase of property and equipment (58,017) (135,982) - - ------------------------------------------------------------------------- Net cash used in investing activities (58,017) (135,982) - - ------------------------------------------------------------------------- Cash flows from financing activities: Proceeds from notes payable, banks 140,000 738,113 10,000 180,000 Principal payments on notes payable, banks (110,000) - - - Proceeds from subordinated notes payable
'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
2. Vermillion Announces Appointment of John Hamilton to Board of Directors
3. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
4. PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend
5. Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director
6. Inimex Announces Appointment of New CEO
7. Spherix Announces the Closing of $6.3 Million Registered Direct Offering
8. Spherix Announces Results of Annual Shareholders Meeting
9. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
10. Netech Corporation Announces the Release of IPA 2000 -- Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps
11. iSirona Announces Go-live at University Hospitals in Cleveland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical ... antiviral therapies, announced today that it will present at ... Investment Conference sponsored by H.C. Wainwright & ... Regis Hotel in New York, NY ... Executive Officer, will provide an overview of the Company,s ...
(Date:9/1/2015)... ... September 01, 2015 , ... AxioMx ... that the National Institutes of Health (NIH) has awarded the company a Phase ... the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. AxioMx will ...
(Date:9/1/2015)... Warren, NJ (PRWEB) , ... September 01, 2015 , ... ... paper that highlights the opportunities for advanced analytics utilizing data lakes in the ... all industries, Healthcare has seen an explosion of data over the last few years ...
(Date:9/1/2015)... ... September 01, 2015 , ... Research conducted by Synedgen Inc.’s ... University School of Medicine, Frederick National Laboratory for Cancer Research, and the Centers ... Open Access journal. , Christopher Ryan PhD, of Synedgen, and Aparajita Chatterjee, ...
Breaking Biology Technology:ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3
... , , , 7.6.4 Long PCR , ... as desired with every temperature , command, enables a , ... , With Long PCR, this function can be used ... elongation. , , ...
... , , , , , ... set of conditions that can be applied to all PCR amplifications. For ... used, the annealing temperatures , of the PCRs can differ ... stringent annealing temperature is a prerequisite for reliable results , ...
... , , , , ... fragment using the PCR* are an everyday occurrence in the lab. For example, , ... which hinder, , or even prevent, further analyses (cycle ... of the PCR result. In such cases, PCR , ...
Cached Biology Technology:PCR Optimization 2PCR Optimization 3Using Gradient PCR to determine the optimum annealing temperature. 2
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/5/2015)... , August 5, 2015 According ... Access Management Market by Software, Services, Vertical (BFSI, Airport, IT ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... Market globally into various segments. The global PIAM Market ... to $546.2 Million by 2019, at a CAGR of ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... acetyl CoA carboxylase 2,or ACC2, appears to turn the ... in part why the animals can eat more and ... Medicine,researchers.,The report that appears online today in the Proceedings ... cells in these mice bred to lack ACC2," said ...
... University,of California, San Diego have invented a process ... of specialized cells being sought as possible,treatments for ... and Shu Chien, UCSD bioengineering professors, and Christopher,J. ... in a paper published in the February issue ...
... have discovered a way to overcome one of the ... kill normal cells in the,process of eradicating cancer cells.,In ... of the Proceedings of the,National Academy of Sciences (PNAS), ... into a specially designed,virus. The virus eradicated prostate cancer ...
Cached Biology News:Lack of enzyme turns fat cells into fat burners 2Priming embryonic stem cells to fulfill their promise 2Priming embryonic stem cells to fulfill their promise 3Columbia research lifts major hurdle to gene therapy for cancer 2